Antiviral Activity Against SARS-CoV-2 Variants Using in Silico and in Vitro Approaches
Description
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emergence in 2019 led to global health crises and the persistent risk of viral mutations. To combat SARS-CoV-2 variants, researchers have explored new approaches to identifying potential
